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A high molecular mass latent form of transforming growth factor type-8 (TGF-B) was purified to homogeneity from 
rat platelets by a seven-step rocedure involving group-specific affinity chromatographies on Red-Toyopearl and zinc 
chelating-Sepharose. The purified latent TGF-B was a complex of TGF-j3 (25 kDa) and the binding protein previously 
named masking protein (-400 kDa) [(1986) Biochem. Biophys. Res. Commun. 141, 176184]. Analysis of the peptide 
structure by gel electrophoresis showed that the masking protein consisted of two subunits of 39 kDa and 105-120 kDa 
linked by disulfide bonds. N-terminal ammo-acid sequencing of the 39 kDa subunit indicated that this subunit was identi- 
cal to the N-terminal part of the TGF-8 precursor. 
Latent transforming rowth factor-/?; Transforming growth factor-/I precursor; N-terminal sequencing; (Rat) 
1. INTRODUCTION 
Transforming growth factor type-D (TGF-P), 
first detected as a tumor growth factor, has been 
shown to be a potent effector of proliferation and 
differentiation of many cell types [ 1,2]. TGF-,B is 
a ubiquitous protein in mammals and the proteins 
in various species show high homology. cDNA 
analysis revealed that human and murine TGF-,& 
are encoded as precursors of 391 amino acid 
residues, and after processing, 112 residues of the 
C-terminal part of the precursor form a 
homodimer linked by a disulfide bridge, i.e. 
mature TGF-fl [3,4]. 
TGF-,~3 issynthesized in most cells, but in normal 
cells and certain transformed cells, secreted TGF-fl 
has no biological activity under physiological con- 
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ditions [5,6]. This latency is due to its formation of 
a complex with a high-molecular-mass binding 
protein that prevents its binding to its cellular 
receptor [7]. The latent complex is dissociated with 
the appearance of TGF-fl activity on drastic in 
vitro treatments, such as with 1 N acetic acid or 
6 M urea [5,6], but the physiological mechanism of 
activation of latent TGF-fl is unknown. 
For understanding the activation mechanism, we 
investigated the binding protein of TGF-fl, and 
previously reported the partial purification of this 
protein [8]. We also found that the dissociated 
binding protein reversibly masked TGF-@ activity, 
and so named this protein ‘masking protein’ (MP). 
Here we report the purification of MP from rat 
platelets in the form of a complex with TGF-,&, i.e. 
latent TGF-/3, and show that the smaller of the two 
subunits of MP is identical to the N-terminal part 
of the TGF-,& precursor. After this work was com- 
pleted, a report of an independent study was 
published that also showed that one of the two 
subunits of the binding protein in latent TGF-/3 
purified to homogeneity from human platelets is 
identical to the N-terminal part of the TGF-/3 
precursor [9]. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Sepharose type chromatography resins and pre-packed HR 
columns were purchased from Pharmacia LKB Biotechnology 
(Uppsala). Toyopearl was from Tosoh Co. (Tokyo). The 
materials used for isolation and culture of adult rat hepatocytes 
were as described in [lo]. [‘2sI]Deoxyuridine, [“sI]UdR 
(2200 Ci/mmol), was obtained from Dupont/NEN Research 
Products (USA). Recombinant human epidermal growth factor 
(EGF) was a gift from Earth Chemical Co. (Hyogo). 
2.2. Assay of TGF-/3 activity 
TGF-fl activity was assayed by measuring its inhibition of 
DNA synthesis in primary cultures of adult rat hepatocytes in- 
duced by insulin and EGF as described elsewhere using 
[‘251]UdR [I 1,121. The latent TGF-,& was activated by acidifica- 
tion of preparations with a final concentration of 0.25% @H 
1.75) trifluoroacetic acid. After incubation at room 
temperature for 20 min, the preparation was neutralized, 
diluted with phosphate-buffered saline (PBS), and added with 
insulin and EGF to hepatocytes in primary culture. All test 
samples for the bio-assay were supplemented with a final con- 
centration of 2.5 mg/ml of bovine serum albumin (BSA) 
(98~99% purity, from Sigma, USA) to prevent non-specific 
adhesion. 
2.3. Purification of [atent TGF,B 
Latent TGF-j3 was obtained from platelets of adult Wistar 
rats. The platelets were isolated from the blood of 500 rats as 
described previously [13], and were sonicated in 50 mM Tris- 
HCl buffer (pH 8.5) supplemented with 0.15 M NaCl, 2 mM 
CaClz and 10 mM Hepes. The preparation was centrifuged at 
3000 x g for 15 min, and the supernatant was applied to a S- 
Sepharose Fast Flow equilibrated with the buffer used for 
sonication. The unadsorbed fraction, which contained latent 
TGF-,8, was collected by the batch method and supplemented 
with the protease inhibitors described in [14] to prevent 
degradation of latent TGF-6, The preparation was applied to a 
Q-Sepharose Fast Flow column (2.6 i.d. x 35 cm) equilibrated 
with 20 mM Tris-HCl @H 7.4) containing 0.15 M NaCl and 
1 mM EDTA. The column was washed with the same buffer 
and then material was eluted on a linear gradient of NaCl in the 
same buffer. The fraction of eluate from Q-Sepharose contain- 
ing latent TGF;B was dialyzed against 20 mM phosphate buffer 
(pH 6.8) containing 0.15 M NaCl, and applied to an AF Red- 
Toyopearl 650 ml column (2.2 i.d. x 20 cm) equilibrated with 
the same buffer as for dialysis. The column was washed with the 
starting buffer and developed with a gradient of O-10 mM 
borate buffer (pH 9.2) containing 0.15 M NaCl and 6 M urea. 
The fraction of eluate containing latent TGF-#7 was sup- 
plemented with a final concentration of 0.5 M NaCl adjusted to 
pH 8.0, and applied to a Chelating-Sepharose Fast Flow col- 
umn (1.0 i.d. x 9 cm) to which zinc ion had been bound and 
which then had been equilibrated with 20 mM phosphate buffer 
(pH 8.0) containing 0.5 M NaCl. After adsorption of the sam- 
ple, the column was developed with a gradient from the 
equilibration buffer to 20 mM citrate-phosphate buffer (pH 
4.0) containing 0.5 M NaCl. The eluate from Zn chelating- 
Sepharose containing latent TGF;B was supplemented with a 
final concentration of 0.3 M ammonium sulfate and adjusted to 
pH 8.5. Then it was applied to a phenyl-Sepharose CL-4B col- 
umn (1 .O i.d. x 6 cm) equilibrated with 20 mM Tris-HCl buffer 
(pH 8.5) containing 0.3 M ammonium sulfate. The column was 
washed and then developed with a gradient from the equilibra- 
tion solution to the same solution without ammonium sulfate. 
Fractions containing latent TGF;B from phenyl-Sepharose were 
pooled and concentrated to 300 ~1 by ultracentrifugation in a 
Centricon- (Amicon Co., USA). The concentrated sample 
was injected into a Superose 12HR lo/30 column equilibrated 
with PBS at pH 7.4 of a loading rate of 0.3 ml/min. The frac- 
tions containing the highly purified latent TGF-,8 were collected 
and finally purified on a Mono Q HR 5/5 column. The Mono 
Q was equilibrated with PBS (pH 7.4) and, after sample ap- 
plication, material was eluted with a gradient of 0.15 M-O.6 M 
NaCl in the same phosphate buffer. 
2.4. SDS-PAGE 
SDS-PAGE was performed by the method of Laemmli 115). 
Samples were heated at 90°C for 5 min in the presence of 1070 
SDS and 8 M urea at pH 6.8 with or without 2% 
2-mercaptoethanol, and then applied to a ready-made gradient 
slab gel of 4-20% polyacrylamide (Daiichi Pure Chemical Co., 
Tokyo). Protein on the gel was stained with Coomassie brilliant 
blue (CBB) R-250 by the method of Burgess (161. On SDS- 
PAGE analysis, the molecular mass was calculated from a 
semilog calibration curve for molecular mass versus distance of 
Table 1 
Summary of the purification of the latent form of TGF-fi 
Total TGF;B Specific 
proteina, activityb, activity, 
mg units units/mg 
(yield W) (purification 
fold) 
Starting materialC 1206 25.8 x lo6 2.1 x 104 
(100) (1.0) 
Q-Sepharose 88 6.0 x lo6 6.8 x 104 
(23) (3.2) 
Red-Toyopearl 7.2 3.3 x 106 4.6 x lo5 
(13) (22) 
Zn-Sepharose 0.86 1.5 x 106 1.7 x 106 
(6) (81) 
Phenyl-Sepharose 0.34 1.3 x 106 3.8 x lo6 
(5) (181) 
Superose 12 0.25 1.4 x 106 5.6 x lo6 
(5) (267) 
Mono Q 0.037 0.27 x lo6 7.3 x lo6 
(1) (348) 
a Protein was measured by analysis with dye-reagent (Bio-Rad 
Lab., USA) except in fractions from Superose 12 and Mono 
Q, in which it was estimated from its absorption using the 
approximate formula: protein concentration (mg/ml) = 
1.45 X A280 - 0.74 X &,, [19] 
b TGF;B activity was assayed after acid-activation 
’ The starting material was an unadsorbed fraction to S- 
Sepharose of lysate of platelets from 500 rats 
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migration obtained with the following marker proteins: myosin 
(200 kDa), ,&galactosidase (116 kDa), phosphorylase (97 kDa), 
BSA (67 kDa), ovalbumin (43 kDa), carbonic anhydrase 
(30 kDa), soybean trypsin inhibitor (20 kDa). 
2.5. N-terminal amino acid sequencing 
Purified latent TGF-j3 was subjected to SDS-PAGE under 
reducing conditions, and then transferred to a polyvinylidene 
difluoride membrane by the method of Matsudaira [17]. After 
Western blotting, proteins on the membrane were detected with 
CBB R-250. Stained spots were cut out and their amino acid se- 
quences were determined in an Applied Biosystems model 470A 
protein/peptide sequencer equipped with an on-line detection 
system, an Applied Biosystems model 120A phenylthiohydan- 
toin (PTH) analyzer. 
3. RESULTS 
3.1. Purification of latent TGF-,8 
Previously, we reported purification from rat 
platelets of the binding protein of TGF-,&, named 
masking protein, in a form dissociated from its 
complex with TGF-@ by treatment with 6 M urea 
[8]. In the present study, we purified MP as a com- 
plex with TGF-fi to obtain information about la- 
tent TGF-fi. 
Hepatocyte growth factor (HGF) is present in a 
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lysate of whole platelets [181. Therefore, the lysate 
was first subjected to cation-exchange S-Sepharose 
chromatography to separate latent TGF-fi from 
HGF, and the unadsorbed fraction was used as 
starting material for purification of latent TGF-fl. 
This material was subjected to the six successive 
column chromatographies described in section 2 
(elution profiles are not shown). Purification of la- 
tent TGF-fl was followed by monitoring growth in- 
hibitory activity on hepatocytes after activation of 
TGF-,& by acidification of the fractions. At all 
steps, TGF-fl activity was detected after acidifica- 
tion, but not without acidification, indicating that 
TGF-fi was present in the latent form (not shown). 
The purification of latent TGF-fl from platelets 
of 500 rats is summarized in table 1. The final yield 
of purified latent TGF-,f3 was 37 pg. 
3.2. Analysis of subunit structure of latent TGF-fl 
by SDS-PAGE 
The protein components of purified latent TGF- 
6 obtained from Mono Q HR 5/5 were analyzed by 
SDS-PAGE with CBB R-250 staining (fig.1). 
Under non-reducing conditions, a band of TGF-fl 
B 
1. 2. 3. 
116- 
97 - 
67 - 
+ HMW-MP 
+ LMW-MP 
monomer 
Fig. 1. SDS-PAGE analysis of latent TGF-fi. Various doses of latent TGF-fi were electrophoresed on gradient gel and then analyzed 
by CBB R-250 staining. Lanes l-3 were loaded with 1, 2 and 4pg protein, respectively. (A) Unreduced sample on 4-20% 
polyacrylamide gel; (B) reduced sample on the same gel. The values on the left indicate positions of marker proteins. HMW and LMW 
mean high and low molecular mass, respectively, and MP means masking protein. 
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Fig.2. N-terminal amino acid sequence of the 39 kDa subunit of 
MP. The sequence determined is boxed. The position of this 
sequence in the precursor of TGF;B is shown diagrammatically. 
The hatched box represents mature TGF-j3 after processing. 
of 25 kDa was observed, and another large compo- 
nent of 180-210 kDa, which was thought to be a 
MP, was detected as a slightly broad band 
(fig.lA). We extracted the 180-210 kDa band 
from the gel and confirmed that it had a masking 
activity against TGF$ (not shown). Under reduc- 
ing conditions, TGF-fl was converted to a 
12.5 kDa monomer and migrated to the same posi- 
tion as the dye front. Furthermore, a high- 
molecular-mass band of MP was converted to 
105-120 kDa and 39 kDa (fig.lB). These findings 
indicated that the latent TGF-fl consisted of three 
components: TGF-fi of 12.5 kDa, and MP 
subunits of 105-210 kDa and 39 kDa. 
3.3. N-terminal sequencing of components of 
latent TGF-p 
The N-terminal amino acid sequence of com- 
ponents of the latent TGF-,f3 was analyzed after 
Western blotting of a reduced sample. The N- 
terminal sequence of the 12.5 kDa component was 
Ala-Leu-Asp-Thr-Asn-Tyr-X-Phe. This sequence 
was identical to the N-terminus of TGF-fl type 1, 
from murine platelets [4]. The N-terminal se- 
quence of the 39 kDa subunit of MP was Leu-Ser- 
Thr-X-Lys-Thr-Ile-Asp-Met-Gln-Leu-Val-Lys-X- 
Lys, which was identical to the N-terminal part of 
the TGF-fl precursor starting 30 residues from the 
initiation site of the transcribed precursor (fig.2). 
No PTH-amino acid was detected in the 
105-120 kDa subunit of MP, indicating that the 
N-terminus of this component was blocked. 
4. DISCUSSION 
Previously, we reported the partial purification 
of MP dissociated from TGF-,& from murine 
platelets [8]. This partially purified MP caused 
dose-dependent neutralization of the activity of rat 
or human TGF-,f3 and was inactivated by reduction 
with dithiothreitol, but not by heat or acid treat- 
ment. In this work, we purified MP to homogenei- 
ty as a complex with TGF-fl and analyzed its 
structure. SDS-PAGE analysis under reducing 
conditions showed that the latent TGF-P was com- 
posed of at least three components: TGF-@ 
monomer of 12.5 kDa, and MP subunits of 
39 kDa and 105-120 kDa. These two MP subunits 
formed a complex of 180-210 kDa in which 
39 kDa subunits were linked with the 
105-120 kDa component by disulfide bonds. The 
180-210 kDa protein extracted from the 
polyacrylamide gel after electrophoresis under 
non-reducing conditions had a masking activity, 
but the 39 kDa and 105-120 kDa components in 
the reduced sample had no activity (not shown). 
The 180-210 kDa component is thought to be the 
minimum active unit for masking of TGF-fi. 
Native MP was estimated by gel-filtration 
chromatography to be a protein of 400-500 kDa 
[6,8]. The 180-210 kDa component separated by 
SDS-PAGE in non-reducing conditions is thought 
to form a dimer with a non-covalent bond(s). 
N-terminal sequencing showed that the 39 kDa 
subunit was identical with the N-terminal part of 
the TGF-fi precursor starting at leucine, residue 30 
from the transcription initiation site. The peptide 
from residue l-29 of the precursor seems to be a 
hydrophobic signal peptide that is cut off during 
processing. The 39 kDa subunit is a little larger 
than the precursor without the signal peptide and 
mature TGF-P, which is calculated to be 28 kDa 
from its amino acid sequence. Because this N- 
terminal part of the precursor has three N- 
glycosylation sites, the 39 kDa subunit is probably 
nearly the same as the N-terminal glycoprotein of 
processed TGF-P. The 39 kDa subunit (N-terminal 
part) and TGF-,& monomer (C-terminal part) are 
probably bound in a 1: 1 molar ratio in latent 
TGF-fl. Therefore, the 39 kDa subunit is thought 
to form a dimer as well as mature TGF-,@. As 
described above, SDS-PAGE analysis indicated 
that a dimer of 39 kDa was bound to the 
105-120 kDa subunit of MP by a disulfide 
bond(s). Thus, we propose that one molecule of 
native latent TGF-P contains two molecules of 
mature TGF-P and a dimer of the 180-210 kDa 
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masking protein, which is composed of two 
39 kDa subunits and a 105-120 kDa subunit. 
Analysis of the partial amino acid sequence of 
the other MP subunit, 105-120 kDa protein, is 
still incomplete, but the role of this component in 
masking and releasing TGF-,& is very interesting. 
We are now studying the primary structure of the 
105-120 kDa subunit of MP by the molecular 
cloning technique. Further structural analysis of 
MP as a regulatory protein for TGF-/? should pro- 
vide information on the physiological mechanism 
of activation of latent TGF-fl. 
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